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Abstract
The majority of studies relating to the oral glucose tolerance test (OGTT)
have not taken gastric emptying (GE), which exhibits a substantial inter-indi-
vidual variation, into account. We sought to evaluate the impact of GE, on
the glycemic and insulinemic responses to a 75-g oral glucose load in older
subjects with normal and impaired glucose tolerance. Eighty-seven healthy
‘older’ subjects (47F, 40M; age 71.0  0.5 year) were given a drink compris-
ing of 75-g glucose and 150 mg C13-acetate made up to 300 mL with water
on a single occasion. Exhaled breath was obtained for analysis of 13CO2 and
calculation of the 50% GE time (T50). Blood glucose, serum insulin and
plasma glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic
peptide (GIP) were measured, and the insulin sensitivity index (ISI), and the
disposition index (DI), were calculated. Thirty-one subjects had normal glu-
cose tolerance (NGT) and 46 had impaired glucose tolerance (IGT). Blood
glucose at t = 60 min and t = 120 min were related inversely to ISI
(P < 0.001) and DI P < 0.001). The rise in blood glucose at t = 60 min was
related inversely to the T50 in all subjects (P < 0.01), and those with IGT
(P < 0.001), but not NGT. There were no significant relationships between
the blood glucose at t = 120 min with the T50, but in both groups the change
in blood glucose from baseline at t = 180 min was related (NGT: P < 0.001;
IGT: P < 0.001) to the T50. We conclude that in NGT and IGT, the effect of
GE on both the ‘early’ and ‘late’ glycemic responses to a 75-g oral glucose
load is complementary to that of insulin sensitivity.
Introduction
The World Health Organisation 75-g oral glucose
tolerance test (OGTT) is regarded as the ‘gold standard’
for the diagnosis of impaired glucose tolerance (IGT) and
diabetes (American Diabetes A 2014) and is also predic-
tive of the development of type 2 diabetes (Abdul-Ghani
et al. 2010). The OGTT does, however, exhibit substantial
variability (Mooy et al. 1996) and there are uncertainties
about the diagnostic value of the traditional 120-min glu-
cose, as opposed to the 60-min value (Abdul-Ghani et al.
2008, 2009). In particular, the 60-min plasma glucose
may correlate better with insulin secretion and resistance
(Abdul-Ghani et al. 2008, 2009).
The variability in the OGTT is likely to be accounted
for, in part, by gastric emptying (GE) which, in health,
exhibits a wide interindividual variation (Collins et al.
1983) so that nutrients, including glucose, usually enter
the small intestine at an overall rate of 1–4 kcal/min, pri-
marily as a result of inhibitory feedback arising from the
small intestine (Brener et al. 1983). This interindividual
variation is increased in longstanding diabetes because of
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the high prevalence of delayed (Horowitz et al. 2001),
and occasionally more rapid, GE (Phillips et al. 1992).
Studies in small cohorts have established that GE is a
major determinant of the initial (from ~15 to 60 min)
glycemic response to oral glucose and carbohydrate-con-
taining meals in healthy volunteers (Horowitz et al. 1993,
1996; Corvilain et al. 1995; Schwartz et al. 1995; O’Dono-
van et al. 2005), type 2 patients with both normal and
disordered GE (Jones et al. 1995; Stevens et al. 2011) and
hypertensive patients (Phillips et al. 1997). It has also
been suggested that more rapid GE may predispose to the
development of type 2 diabetes (Phillips et al. 1992). The
dependence of postprandial glycemia on GE provides a
rationale for the use of dietary and/or pharmacological
(most recently, ‘short-acting’ glucagon-like peptide-1
(GLP-1) agonists) interventions which slow GE to reduce
postprandial glycemic excursions (Linnebjerg et al. 2008).
In contrast to the above, there is much less information
about the relationship of the blood glucose level at 120 min
during an OGTT with GE (Horowitz et al. 1993; Corvilain
et al. 1995). Horowitz et al. reported that, in health, this
relationship is positive, rather than inverse, presumably
reflecting the insulin levels achieved earlier (Horowitz et al.
1993). This also appears to apply to the blood glucose at
180 min (Corvilain et al. 1995). To our knowledge, there is
no information about the impact of GE on the 120-min
blood glucose in patients with IGT, or type 2 diabetes. Fur-
thermore, studies which have evaluated the effect of GE on
the glycemic response to glucose have not assessed insulin
secretion, or sensitivity. The incretin hormones, GLP-1 and
glucose-dependent insulinotropic peptide (GIP), modulate
the glycemic response to oral carbohydrate (Nauck et al.
1986) and their secretion may be influenced by the rate of
GE (Pilichiewicz et al. 2007).
We hypothesized that GE would have a complementary
effect to that of insulin sensitivity on the glycemic and
insulinemic responses to a 75-g oral glucose load. This
hypothesis could potentially be addressed by manipulating
GE in isolation, which is problematic. Given the substan-
tial interindividual variation in GE, we have quantified
GE as well as both ‘early’ and ‘late’ glycemic responses,
and insulin sensitivity in a cohort of older subjects with
either normal glucose tolerance (NGT) or IGT.
Materials and Methods
Subjects
Eighty-seven healthy ‘older’ subjects (47 female and 40
male, mean age 71.0  0.5 years [range: 65–90 years],
body mass index [BMI] 26.0  0.3 kg/m2 [range: 20.3–
30.5 kg/m2]), were recruited by advertisements placed in
the local hospital campus and newspaper. Prior to their
inclusion, demographic information and a basic medical
history were obtained. Subjects with a history of gastroin-
testinal disease or surgery, known diabetes, significant
respiratory or cardiac disease, alcohol abuse (consump-
tion >20 g/day) or epilepsy, were excluded. Any medica-
tion was withheld for 24 h prior to the study.
Protocol
In each subject, concurrent measurements of GE, blood
glucose, serum insulin, and plasma GLP-1 and GIP were
obtained on a single study day, which commenced at
0830 h after an overnight fast from solids for 14 h and
liquids for 12 h. Upon arrival, an intravenous (IV) can-
nula was inserted into an antecubital vein for blood sam-
pling while the subject was supine. The subject was then
seated and allowed to ‘rest’ for 15–30 min before consum-
ing a drink containing 75-g glucose and 150-mg C13-ace-
tate (Cambridge Isotope Laboratories, Tewksbury, MA),
made up to 300 mL with water, within 3 min; t = 0 min
was defined as the time of completion of the drink.
Exhaled breath samples were collected in hermetically
sealed 10-mL tubes (Exetainer, Buckinghamshire, Eng-
land) prior to the ingestion of the drink (t = 3 min),
every 5 min for the first hour, and then every 15 min for
the subsequent 3 h, for assessment of GE. Venous blood
samples, for measurement of blood glucose, serum insu-
lin, plasma GLP-1, and plasma GIP, were obtained in
tubes containing EDTA at t = 3, 15, 30, 45, 60, 90, 120,
180, and 240 min, centrifuged at 1490 g for 15 min and
plasma, or serum, separated, and stored at 70°C. At
t = 240 min the IV cannula was removed and the subject
offered a light lunch prior to them leaving the laboratory.
The protocol was approved by the Research Ethics Com-
mittee of the Royal Adelaide Hospital, and each subject
provided written, informed consent. All experiments
were carried out in accordance with the Declaration of
Helsinki.
Gastric emptying
The 13CO2 concentration in breath samples was measured
by an isotope ratio mass spectrometer (ABCA 20/20;
Europa Scientific, Crewe, UK) with an online gas
chromatographic purification system. The gastric 50%
emptying time (T50) was calculated (Ghoos et al. 1993).
Blood glucose, serum insulin, plasma GLP-1,
and plasma GIP
Blood glucose (mmol/L) was determined using a portable
glucometer (Medisense Companion 2 meter, Medisense
Inc., Waltham, MA) and each subject classified, according
2014 | Vol. 2 | Iss. 11 | e12204
Page 2
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
Gastric Emptying and Glucose Tolerance L. G. Trahair et al.
to WHO (Alberti and Zimmet 1998) criteria, as having
NGT (fasting blood glucose <6.1 mmol/L, and 2 h
<7.8 mmol/L), impaired fasting glucose (IFG) (fasting
blood glucose <7.0 mmol/L, but >6.1 mmol/L), IGT (2 h
blood glucose <11.1 mmol/L, but >7.8 mmol/L), or diabe-
tes (fasting blood glucose ≥7.0 mmol/L and/or 2 h blood
glucose ≥11.1 mmol/L) (Alberti and Zimmet 1998).
Serum insulin was measured by ELISA immunoassay
(10-1113, Mercodia, Uppsala, Sweden). The sensitivity was
1.0 mU/L and the coefficient of variation (CV) was 2.6%
within, and 7.6% between, assays (Trahair et al. 2012).
Total GLP-1 was measured by radioimmunoassay (GLPIT-
36HK, Millipore, Billerica, MA). Minimum detectable limit
was 3 pmol/L, intra and interassay CVs were 7.7% and
9.4%, respectively (Trahair et al. 2012). Plasma GIP was
measured by radioimmunoassay. Minimum detectable
limit was 2 pmol/L, interassay CV was 8.7%, and intraassay
CV was 5.0% (Wishart et al. 1992).
Insulin sensitivity and disposition index
The insulin sensitivity index (ISI) of Matsuda and
DeFronzo (1999) was calculated as follows:
where insulin is in mU/L and glucose is in mg/dL. The
ratio of the incremental changes from baseline in insulin
and glucose at 30 min (ΔI30/ΔG30) was calculated as a
measure of b-cell function (Phillips et al. 1994). Insulin
secretion, corrected for b-cell function (the oral disposi-
tion index [DI]), was calculated as the product of the
Matsuda index and b-cell function (ΔI30/ΔG30*ISI) (Kim
et al. 2012).
Statistical analysis
For blood glucose, serum insulin, and plasma GLP-1 and
GIP, changes from baseline and total areas under the curve
(AUC) at t = 60, 120, 180, and 240 min were calculated.
Changes in each variable over time as were evaluated with a
one-way repeated measures ANOVA. Data in subjects with
NGT and IGT were compared (excluding subjects with IFG
alone, or diabetes) using Student’s t-test. Pearson’s
correlation was used to evaluate relationships between vari-
ables. A multiple regression model was used to assess the
determinants of the blood glucose at t = 60, 120, and
180 min. In this model, covariates included the T50, ISI,
and DI. Results of the multiple regressions are reported as
adjusted R2 (R2Adj). Semipartial correlations are reported
for the variables within each regression (RPart). A P < 0.05
was considered significant in all analyses. The statistical
analysis was supervised and reviewed by a professional
biostatistician (KL). Data are presented as mean
values  SEM.
Results
The studies were well tolerated and there were no adverse
events. Thirty-one subjects had NGT, 32 had IGT, and 14
had both IFG and IGT; that is, 46 had IGT. Eight had
IFG alone and two had diabetes; these 10 subjects were
excluded from the analysis, resulting in a cohort of 77
subjects. Demographic variables in the subjects are pro-
vided in Table 1. There were no differences in age or
BMI between the groups with IGT and NGT. In three
subjects (one NGT, two IGT), GE data were unavailable
due to degradation of the breath samples; in one the
t = 180 and 240-min blood samples and in another the
t = 240-min sample, were unavailable as the cannula was
not patent. In two subjects, the insulin sample at
t = 240 min was lost.
Gastric emptying
The GE T50 was 140.5  4.3 min (n = 74, range: 95–
256 min). There was no difference in the T50 between the
groups with IGT and NGT (139.5  5.7 min vs.
141.8  6.5 min, P = 0.80).
Blood glucose, serum insulin, plasma GLP-1,
and plasma GIP
Blood glucose increased following the drink (P < 0.001)
and was less than baseline at both t = 180 and 240 min
Table 1. Demographic variables in the whole cohort (n = 77),
subjects with NGT (n = 31) and IGT (n = 46).
Whole group NGT IGT
Age (years) 70.8  0.5 69.8  0.7 71.5  0.7
Sex 39F, 38M 12F, 19M 27F, 19M
BMI (kg/m2) 26.0  0.3 25.6  0.5 26.2  0.4






Data are mean  SEM. BMI, body mass index; GE, gastric 50%
emptying time (T50); IGT, impaired glucose tolerance; NGT, normal
glucose tolerance.
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(P < 0.001 for both) (Fig. 1A). In the group with IGT
when compared with those with NGT, blood glucose was
greater at baseline, t = 15, 30, 45, 60, 90, 120, and
180 min (P < 0.05 for all), but not at t = 240 min
(P = 0.34), and the AUC for blood glucose was greater at
t = 60, 120, 180, and 240 min (P < 0.001 for all)
(Fig. 1A).
Serum insulin increased following the drink
(P < 0.001) and had returned to baseline by t = 240 min
(Fig. 1B). In the group with IGT when compared to those
with NGT, serum insulin was greater at t = 90, 120, and
180 min (P < 0.05 for all) (Fig. 1B).
There was an increase in plasma GLP-1 following the
drink (P < 0.001), with a peak at ~t = 30 min and levels
returning to baseline by t = 180 min (Fig. 1C). There was
a sustained increase in plasma GIP (P < 0.001) until
t = 120 min (Fig. 1D). There were no differences in abso-
lute levels, or the AUC, for plasma GLP-1 or GIP between
the groups with NGT or IGT (Fig. 1D).
Insulin Sensitivity Index, b-cell function, and
Disposition Index
In NGT, ISI (8.6  0.9 vs. 6.0  0.5, P < 0.01), ΔI30/
ΔG30 (15.2  1.8 vs. 9.4  0.9, P < 0.05), and DI
(110.1  13.1 vs. 54.3  9.2, P < 0.001) were greater
when compared with those with IGT.
Relationships between blood glucose, serum
insulin, insulin sensitivity, and incretin
hormones
Glucose at 60 min
In the whole group (n = 77) the blood glucose at
t = 60 min was related directly to the fasting blood glu-
cose (R = 0.50, P < 0.001) and insulin (R = 0.28,
P < 0.005), as well as the rise in insulin between t = 0–
60 min (R = 0.33, P < 0.005) and inversely to the ISI
(R = 0.48, P < 0.001) and DI (R = 0.68, P < 0.001).
Similarly, the rise in blood glucose at t = 60 min was
related inversely to the ISI (R = 0.45, P < 0.001) and
DI (R = 0.68, P < 0.001).
In subjects with NGT (n = 31) the blood glucose at
t = 60 min was related to fasting glucose (R = 0.38,
P < 0.05), fasting insulin (R = 0.36, P < 0.05), and the
rise in insulin between t = 0–60 min (R = 0.40,
P < 0.05). In IGT (n = 46) the blood glucose at
t = 60 min was also related to fasting glucose (R = 0.35,
P < 0.05) and the rise in insulin between t = 0–60 min
(R = 0.40, P < 0.01). In both groups, the blood glucose
at t = 60 min was related inversely to both the ISI (NGT:
R = 0.36, P < 0.05; IGT: R = 0.45, P < 0.005) and DI




Figure 1. Blood glucose (A), serum insulin (B), plasma GLP-1 (C), and plasma GIP (D) immediately before and after a 75-g oral glucose load in
all subjects (▲, n = 77), subjects with normal glucose tolerance (●, n = 31) and those with impaired glucose tolerance ( impaired fasting
glucose) (■, n = 46) (*P < 0.05 NGT vs. IGT).
2014 | Vol. 2 | Iss. 11 | e12204
Page 4
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
Gastric Emptying and Glucose Tolerance L. G. Trahair et al.
Glucose at 120 min
In the whole group, the blood glucose at t = 120 min was
related to the fasting blood glucose (R = 0.45, P < 0.001),
insulin (R = 0.29, P < 0.01), and insulin at t = 120 min
(R = 0.43, P < 0.001) and inversely to the ISI
(R = 0.43, P < 0.001) and DI (R = 0.53, P < 0.001).
Similarly, the change in blood glucose at t = 120 was
related inversely to both the ISI (R = 0.37, P < 0.005)
and DI (R = 0.50, P < 0.001).
In NGT, the blood glucose at t = 120 min was not
related to fasting serum insulin, but there was a relationship
with serum insulin at t = 120 min (R = 0.38, P < 0.05); in
IGT, blood glucose at t = 120 min was related to fasting
serum insulin (R = 0.33, P < 0.05), but not the serum
insulin at t = 120 min. In contrast, the blood glucose at
120 min was related inversely to both the ISI (NGT:
R = 0.45, P < 0.05; IGT: R = 0.31, P < 0.05) and DI
(NGT: R = 0.58, P < 0.001; IGT: R = 0.35, P < 0.05).
In NGT, there was no relationship between the change in
blood glucose at t = 120 min and the ISI (R = 0.20,
P = 0.17), however, there was an inverse relationship with
DI (R = 0.31, P < 0.05) and in IGT, the change in blood
glucose at t = 120 min was related inversely to both the ISI
(R = 0.38, P < 0.05) and DI (R = 0.53, P < 0.005).
GLP-1 and GIP
There were no significant relationships between either the
absolute, or rises in plasma GLP-1 or GIP with blood glu-
cose at t = 60 or 120 min in the whole group, or in NGT
or IGT. In the whole group, there was a relationship
between plasma GLP-1 at t = 60 min and insulin at
t = 60 min (R = 0.35, P < 0.005), which was significant
in IGT (R = 0.44, P < 0.005), but not NGT (R = 0.20,
P = 0.29). There was no relationship between plasma GIP
and insulin at t = 60 min.
Relationships with gastric emptying
Glucose and insulin at 60 min
In the whole group (n = 74), there were inverse relation-
ships between rises in both blood glucose (R = 0.30,
P < 0.01, Fig. 2A) and serum insulin (R = 0.23,
P < 0.05) between t = 0–60 min and the T50. Similarly,
there were inverse relationships between the absolute
blood glucose (R = 0.27, P < 0.05) and serum insulin
(R = 0.23, P < 0.05) at t = 60 min and the T50.
In the group with NGT (n = 30) neither the rises in,
or absolute, blood glucose (R = 0.10, P = 0.54, Fig. 2B)
and serum insulin (R = 0.27, P = 0.14) between t =
0–60 min were related to the T50. In contrast, in IGT
(n = 44) both the rise in blood glucose (R = 0.47,
P < 0.001, Fig. 2C), absolute blood glucose (R = 0.43,
P < 0.005) and the AUC (R = 0.36, P < 0.05) from
t = 0–60 min, but not serum insulin were related inver-
sely to the T50.
Glucose and insulin at 120 min
In the whole group, there was no relationship between
the absolute, change in, or AUC for, blood glucose or
serum insulin at t = 120 min and the T50 (Fig. 3A), how-
ever, in subjects with NGT there was a trend for a rela-
tionship between both the change in blood glucose
between t = 0–120 min (R = 0.34, P = 0.06) and the
absolute blood glucose at t = 120 min (R = 0.34,
P = 0.06, Fig. 3B), but not the AUC for blood glucose at
t = 120 min (R = 0.03, P = 0.87) and the T50. In the
group with IGT, the AUC for blood glucose (but not the
absolute or change in blood glucose) at t = 120 min was
related inversely to the T50 (R = 0.34, P < 0.05,
Fig. 3C).
A B
Figure 2. Relationships between the rise in blood glucose between t = 0–60 min and the T50 in (A) all subjects (n = 74, R = 0.30, P < 0.01),
(B) NGT (●, n = 30, R = 0.10, P = NS) and IGT (■, n = 44, R = 0.47, P < 0.001).
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Glucose and insulin at 180 min
In contrast to the rise, in the whole group there was a
relationship between the change in blood glucose at
t = 180 min (R = 0.55, P < 0.001, Fig. 4A) and the T50.
The absolute blood glucose at t = 180 min was also
related to the T50 (R = 0.56, P < 0.001). Similarly, in the
whole group both the change in (R = 0.54, P < 0.001),
and absolute (R = 0.43, P < 0.001) serum insulin at
t = 180 min were related to the T50.
In the NGT group, the absolute blood glucose
(R = 0.74, P < 0.001), and serum insulin (R = 0.48,
P < 0.01) at t = 180 min, and change in blood glucose
(R = 0.73, P < 0.001, Fig. 4B) and serum insulin
(R = 0.55, P < 0.005) between t = 0–180 min, were
related to the T50. In the IGT group, the absolute blood
glucose (R = 0.53, P < 0.001) and serum insulin (IGT:
R = 0.44, P < 0.001) at t = 180 min and the change in
blood glucose (R = 0.50, P < 0.001, Fig. 4C) and serum
insulin (R = 0.57, P < 0.001) between t = 0–180 min,
were related to the T50.
Determinants of the absolute and rises in
blood glucose
Glucose at 60 min
In the whole group (n = 74), a multivariable model
incorporating the ISI, DI, and T50, with the absolute
blood glucose at t = 60 min as the dependent variable,
was significant (P < 0.001), with individual significance
for the ISI (P < 0.05), DI (P < 0.01) and the T50
(P < 0.05) (Table 2). In the group with NGT (n = 30) an
identical model was significant (P < 0.001), however, the
DI was the only significant variable in this model
(P < 0.001). In the group with IGT (n = 44), this model
was significant (P < 0.001) with significance for the T50
(P < 0.05), DI (P < 0.005), and a trend for the ISI
(P = 0.08).
In the whole group, a model incorporating the ISI, DI,
and T50, with the rise in blood glucose at t = 60 min as
the dependent variable, was significant (P < 0.001), with
significance for the DI (P < 0.01) and T50 (P < 0.05), and
A B C
Figure 3. Relationships between absolute blood glucose at t = 120 min and the T50 in (A) all subjects (n = 74, R = 0.01, P = NS) and (B) NGT
(n = 30, R = 0.34, P = 0.06) and between blood glucose AUC 0–120 min and the T50 in (C) IGT (n = 44, R = 0.34, P < 0.05).
A B C
Figure 4. Relationships between the change from baseline for blood glucose between t = 0–180 min and the T50 in (A) all subjects (n = 74,
R = 0.55, P < 0.001), (B) NGT group (n = 30, R = 0.73, P < 0.001), and (C) the IGT group (n = 44, R = 0.50, P < 0.001).
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a trend for the ISI (P = 0.06). In the group with NGT,
this model was significant (P < 0.005), with the DI
(P < 0.001) as the only significant variable. In the group
with IGT this model was significant (P < 0.001), with sig-
nificance for the DI (P < 0.005) and T50 (P < 0.01) only
(Table 2).
Glucose at 120 min
In the whole group, a multivariable model incorporating
the ISI, DI, and T50, with the absolute level of blood glu-
cose at t = 120 min as the dependent variable, was signif-
icant (P < 0.001), with significance for the ISI (P < 0.05)
and DI (P < 0.01), but not the T50. In the group with
NGT this model was significant (P < 0.001) with signifi-
cance for the DI (P < 0.01), and a trend for ISI
(P = 0.06) and T50 (P = 0.07). In the group with IGT,
there was a trend for this model to be significant
(P = 0.06).
In the whole group, a model incorporating the ISI, DI,
and T50, with the change in blood glucose at t = 120 min
as the dependent variable, was significant (P < 0.001),
with the DI (P < 0.001) as the only significant variable.
In the group with NGT this model was significant
(P < 0.005) with significance for the DI (P < 0.01) and a
trend for the T50 (P = 0.08). In the group with IGT, this
model was not significant (Table 2).
Glucose at 180 min
In the whole group, a multivariable model incorporating
the ISI, DI, and T50, with the absolute level of blood glu-
cose at t = 180 min as the dependent variable, was signif-
icant (P < 0.001), with significance for the T50 only
(P < 0.001). In the group with NGT this model was sig-
nificant (P < 0.001) with the T50 as the only significant
variable (P < 0.001). In the group with IGT this model
was significant (P < 0.001), with significance for the T50
(P < 0.001), and a trend for the DI (P = 0.06).
In the whole group, a model incorporating the ISI, DI,
and T50, with the change in blood glucose at t = 180 min
as the dependent variable, was significant (P < 0.001),
with significance for the T50 only (P < 0.001). In the
group with NGT this model was significant (P < 0.001)
with significance for the T50 only (P < 0.001). In the
group with IGT this model was significant (P < 0.005)
with a significance for the T50 (P < 0.001), and a trend
for the DI (P = 0.08) (Table 2).
Table 2. Relationships of glycemia with gastric emptying (T50), insulin sensitivity index (ISI) and disposition index (DI).
Blood glucose time Variable All subjects (n = 74) NGT (n = 30) IGT (n = 44)
60 min Overall model R2Adj = 0.52, P < 0.001 R
2
Adj = 0.38, P < 0.001 R
2
Adj = 0.45, P < 0.001
T50 RPart = 0.21, P < 0.05 RPart = 0.20, P = 0.18 RPar = 0.29, P < 0.05
ISI RPart = 0.19, P < 0.05 RPart = 0.14, P = 0.35 RPar = 0.21, P = 0.08
DI RPart = 0.49, P < 0.01 RPart = 0.57, P < 0.001 RPar = 0.35, P < 0.005
CFB 60 min Overall model R2Adj = 0.52, P < 0.001 R
2
Adj = 0.38, P < 0.005 R
2
Adj = 0.44, P < 0.001
T50 RPart = 0.24, P < 0.05 RPart = 0.22, P = 0.15 RPar = 0.33, P < 0.01
ISI RPart = 0.16, P = 0.06 RPart = 0.12, P = 0.44 RPar = 0.14, P = 0.22
DI RPart = 0.51, P < 0.01 RPart = 0.57, P < 0.001 RPar = 0.37, P < 0.005
120 min Overall model R2Adj = 0.32, P < 0.001 R
2
Adj = 0.41, P < 0.001 R
2
Adj = 0.12, P = 0.06
T50 RPart = 0.07, P = 0.48 RPart = 0.27, P = 0.07 RPar = 0.07, P = 0.64
ISI RPart = 0.22, P < 0.05 RPart = 0.28, P = 0.06 RPar = 0.20, P = 0.17
DI RPart = 0.38, P < 0.01 RPart = 0.42, P < 0.01 RPar = 0.23, P = 0.11
CFB 120 min Overall model R2Adj = 0.27, P < 0.001 R
2
Adj = 0.34, P < 0.005 R
2
Adj = 0.04, P = 0.19
T50 RPart = 0.06, P = 0.56 RPart = 0.27, P = 0.08 RPar = 0.04, P = 0.80
ISI RPart = 0.18, P = 0.08 RPart = 0.23, P = 0.14 RPar = 0.10, P = 0.52
DI RPart = 0.38, P < 0.001 RPart = 0.40, P < 0.01 RPar = 0.23, P = 0.13
180 min Overall model R2Adj = 0.35 P < 0.001 R
2
Adj = 0.53, P < 0.001 R
2
Adj = 0.31, P < 0.001
T50 RPart = 0.58, P < 0.001 RPart = 0.76, P < 0.001 RPart = 0.58, P < 0.001
ISI RPart = 0.09, P = 0.37 RPart = 0.12, P = 0.34 RPart = 0.01, P = 0.97
DI RPart = 0.16, P < = 0.09 RPart = 0.16, P = 0.22 RPart = 0.25, P = 0.06
CFB 180 min Overall model R2Adj = 0.29, P < 0.001 R
2
Adj = 0.52, P < 0.001 R
2
Adj = 0.26, P < 0.005
T50 RPart = 0.56, P < 0.001 RPart = 0.75, P < 0.001 RPart = 0.54, P < 0.001
ISI RPart = 0.01, P = 0.96 RPart = 0.08, P = 0.54 RPart = 0.10, P = 0.47
DI RPart = 0.13, P = 0.21 RPart = 0.19, P = 0.19 RPart = 0.24, P = 0.08
CFB, change from baseline; DI, disposition index; IGT, impaired glucose tolerance; ISI, insulin sensitivity index; NGT, normal glucose tolerance;
R2Adj, adjusted R
2; RPart, semipartial correlation; T50, gastric 50% emptying time.
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Discussion
We have observed that the magnitude of the rise in blood
glucose at 60 min is more closely related to GE in sub-
jects with IGT than in those with NGT (i.e., when GE is
relatively more rapid, the rise in glucose is proportionally
greater), whereas the glycemic response at 120 min
tended to be related positively to GE (i.e., T50) in subjects
with NGT, but was inversely related in those with IGT,
probably reflecting the earlier insulinemic response. We
have also confirmed that the blood glucose levels at 60
and 120 min following an OGTT are related to insulin
sensitivity in healthy older subjects.
Assessment of the relationship of GE with glycemia is
complicated by their interdependency. Acute elevations in
glycemia slow GE (Fraser et al. 1990), whereas GE is a
determinant of glycemia (Horowitz et al. 1993). It has been
assumed that the initial rise in blood glucose is modulated
primarily by first-phase insulin secretion and hepatic insu-
lin sensitivity (Reaven et al. 1993). Given its potential diag-
nostic relevance (Abdul-Ghani et al. 2008, 2009), we
selected the blood glucose value at 60 min to reflect the
‘early’ glycemic response. Our study demonstrates that the
relationship of glycemia and GE is time-dependent, likely
reflecting changes in insulin sensitivity and secretion,
whereas the blood glucose at 60 min was only significantly
related to the rate of GE in the group with IGT. It should
be appreciated that in NGT, the smaller variance in blood
glucose at 60 min, as well as the earlier peak, may have
contributed to the absence of a correlation. Interestingly, at
180-min, blood glucose levels were related to the rate of GE
in both groups and in this case the relationship was inverse,
that is, when GE was relatively more rapid, the blood glu-
cose at 180 min was less, presumably reflecting the propor-
tionally greater insulin responses that occurred at earlier
time points. Studies, utilizing intraduodenal infusions of
glucose, have provided evidence that the relationships
between small intestinal glucose delivery and initial glyce-
mic and insulinemic responses are nonlinear in both health
(Pilichiewicz et al. 2007) and type 2 diabetes (Ma et al.
2012). That such a relationship was not observed in this
study may reflect a lack of subjects with GE rates close to
the upper limit of the normal range. With a breath test, the
GE T50 should be regarded as notional, rather than precise,
despite the demonstrated close correlation with scintigra-
phy (Ghoos et al. 1993), however, it is likely that in the
majority of subjects GE was <2 kcal/min, which is associ-
ated with only modest glycemic and GLP-1 responses (Pil-
ichiewicz et al. 2007).
There were no differences in either the GIP, or GLP-1
responses between the NGT and the IGT groups, consis-
tent with previous observations (Nauck et al. 2004).
However, in NGT the maximum glycemic response only
modestly exceeded the threshold (8–10 mmol/L) for insu-
linotropic effects of GIP and GLP-1 (Toft-Nielsen et al.
2001), unlike the case in subjects with IGT. Hence, the
secretion of GIP and GLP-1 may be of greater relevance
as a compensatory mechanism in the latter group and
contribute to hyperinsulinemia. We did not measure
plasma glucagon, which is also modulated by both GIP
and GLP-1 in a glucose-dependant manner (Vilsboll et al.
2003). Insulin sensitivity and glucose disposition are rec-
ognized major determinants of the glycemic response to
oral glucose (Reaven et al. 1993). We calculated the ISI as
described by Matsuda, and the DI adjusted for b-cell
function and these were shown to be determinants of the
rises in blood glucose at both 60 and 120 min, as would
be predicted. It is well established that in cases of NGT,
insulin sensitivity may be comparable to that in type 2
patients; however, it is only once the b-cell loses its
capacity to compensate for the impaired insulin action
that blood glucose concentrations increase.
Our observations are consistent with the concept that
GE is a major determinant of the initial glycemic response
to carbohydrate-containing meals in type 2 diabetes and
impacts on the overall glycemic response (Jones et al.
1995). It is intuitively likely that GE will assume increased
importance in type 2 patients as b-cell function declines;
GLP-1 is of particular relevance given the diminished in-
sulinotropic effects of GIP (Nauck et al. 1993) and studies
in type 2 patients employing mixed meals are indicated.
While it should be recognized that blood glucose was
quantified by glucometer, with its inherent limitations,
our study supports the concept that the plasma glucose at
60 min during an OGTT provides clinically meaningful
information (Bardini et al. 2010); a cut-off of 8.6 mmol/L
may represent a risk factor for type 2 diabetes (Abdul-
Ghani et al. 2008, 2009; Bardini et al. 2010). However, it
may also represent a marker of relatively rapid GE per se.
It should also be recognized that our cohort was exclu-
sively >65 years old and that aging is characterized by
diminished glucose tolerance, reflecting impairments in
insulin sensitivity and b-cell function (Korosi et al. 2001;
Chang et al. 2006). There is also a modest slowing of gas-
tric emptying with age, but the rate of emptying usually
falls within the normal range for the healthy young
(Moore et al. 1983; Horowitz et al. 1984).
We conclude that the rate of GE and insulin sensitivity
appear to be independent, and complementary, determi-
nants of both the ‘early’ and ‘late’ responses to an OGTT
in healthy older subjects.
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